On Apr. 27, 2020, Diffusion Pharmaceuticals announced the pre-IND submission to the FDA of a planned clinical program…
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…
On Apr. 27, 2020, Atossa Therapeutics announced that it had contracted with NYC Health + Hospitals/Metropolitan in New…
On Apr. 25, 2020, the World Health Organization (WHO) there was currently ‘no evidence’ that people who have…
On Apr. 24, 2020, the U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication regarding known…
On Apr. 24, 2020, a new study led by researchers at Oxford and Guangdong Centre for Diseases Control…
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
On Apr. 24, 2020, researchers at the University of Oxford announced the start of a large, international study…
On Apr. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $749,999 to…
On Apr. 24, 2020, BioSig Technologies announced that subsidiary ViralClear had submitted an Investigational New Drug (IND) application…
On Apr. 23, 2020, Baxter announced it had received emergency use authorization (EUA) from the FDA for the…
On Apr. 22, 2020, the FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen…
On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
On Apr. 23, 2020, researchers from the University of Oxford are supporting a new government study to track…
On Apr. 23, 2020, AstraZeneca and and Saint Lukeﾒs Mid America Heart Institute initiated a randomised, global Phase…
On Apr. 23, 2020, a study led by researchers at Oxford and Guangdong Centre for Diseases Control and…
On Apr. 23, 2020, the Wellcome Sanger Institute announced that two specific cell types in the nose has…
On Apr. 23, 2020, two significant international studies involving hundreds of scientists, including a human geneticist at the…
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…
On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…
On Apr. 23, 2020, Insmed announced that it will provide funding and clinical drug supply for the STOP-COVID19…
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…
On Apr. 22, 2020, the CDC and the USDA National Veterinary Services Laboratories announced the first confirmed cases…
On Apr. 22, 2020, LivaNova announced that several of its cardiopulmonary products are now permitted to be used…
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…